XNASHUMA
Market cap530mUSD
Jan 14, Last price
4.12USD
1D
-6.15%
1Q
-29.09%
IPO
-57.39%
Name
Humacyte Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
-100.00%
Net income
-111m
L
CFO
-73m
L+3.06%
Earnings
Mar 20, 2025
Profile
Alpha Healthcare Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 1,565 23.91% | ||||
Cost of revenue | 173,490 | 94,398 | |||
Unusual Expense (Income) | |||||
NOPBT | (173,490) | (92,833) | |||
NOPBT Margin | |||||
Operating Taxes | (76,184) | ||||
Tax Rate | |||||
NOPAT | (173,490) | (16,649) | |||
Net income | (110,776) -272.50% | 64,219 71.09% | |||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 566 | 535 | |||
BB yield | -0.19% | -0.25% | |||
| Debt | |||||
Debt current | 5,226 | 8,571 | |||
Long-term debt | 73,799 | 58,042 | |||
Deferred revenue | |||||
Other long-term liabilities | 41,341 | 28,605 | |||
Net debt | (1,423) | (85,266) | |||
| Cash flow | |||||
Cash from operating activities | (73,305) | (71,129) | |||
CAPEX | (2,280) | (1,048) | |||
Cash from investing activities | (173) | 4,845 | |||
Cash from financing activities | 4,507 | (1,446) | |||
FCF | (168,341) | (9,550) | |||
| Balance | |||||
Cash | 80,448 | 151,879 | |||
Long term investments | |||||
Excess cash | 80,448 | 151,801 | |||
Stockholders' equity | (537,304) | 116,928 | |||
Invested Capital | 652,310 | 76,365 | |||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 103,420 | 103,051 | |||
Price | 2.84 34.60% | 2.11 -70.90% | |||
Market cap | 293,713 35.08% | 217,438 -24.97% | |||
EV | 292,290 | 132,172 | |||
EBITDA | (165,771) | (84,623) | |||
EV/EBITDA | |||||
Interest | 1,132 | 6,200 | |||
Interest/NOPBT | |||||